Vesiculobullous Disease Flashcards
5 types of hypersensitivity
Type 1 – allergy (immediate anaphylaxis)
Type 2 - antibody-mediated immune reaction in which IgG or IgM are directed against cellular/extracellular matrix antigens, resulting in cellular destruction, functional loss, or damage to tissues. CYTOTOXIC antigen on antibody
Type 3 - an abnormal immune response is mediated by the formation of antigen-antibody aggregates called “immune complexes.”
Type 4 – delayed cell-mediated reaction (T lymphocytes)
Type 5 - antibodies are produced with the property of stimulating specific cell targets
2 types of immunogenic responses
Cell mediated immunity
Antibody mediated immunity
2 local oral immunogenic diseases
Aphthous ulcers
Lichen Planus
Orofacial Granulomatosis
systemic immunogenic diseases with local effects on oral mucosa
6
Erythema Multiforme
Pemphigus
Pemphigoid
Lupus erythematosis
Systemic Sclerosis
Sjogren’s Syndrome
erythema multiforme is result of which hypersensitivty type
3
immune complex (antigen-antibody aggregates)
cell mediated immunogenic diseases which effect oral cavity
3
Aphthous ulcers
Lichen Planus
Orofacial Granulomatosis
antibody mediated immunogenic diseases which effect the oral cavity
2
Pemphigus
Pemphigoid
skin, oral, genital mucosa share
many common antigens and epitopes
epitopes
large immunogenic site within the protein site
antibody binding to epitopes on mucosa
Antibody will only bind to small parts of it (e.g. different epitopes sequences within the antibody)
Antigen antibody binding will affect the shape/conformation of the protein antigen and the change in shape will dictate the changes which are seen clinically
what causes loss of cell-cell adhesion in blistering diseases
Auto-antibody attack on skin components causing loss of cell-cell adhesion
* ‘Split’ forms in skin
* Fills with inflammatory exudate
Forms vesicle/blister (size of lesion (1-2mm vesicle, blister larger)
TARGET for antibodies - Desmoglein (DSG1 and 3)
what causes loss of cell-cell adhesion in blistering diseases
Auto-antibody attack on skin components causing loss of cell-cell adhesion
* ‘Split’ forms in skin
* Fills with inflammatory exudate
Forms vesicle/blister (size of lesion (1-2mm vesicle, blister larger)
TARGET for antibodies - Desmoglein (DSG1 and 3)
target for many autoantibodies in immunobullous/blistering conditions
Desmoglein (DSG1 and 3)
types of immunofluorescence
direct
indirect
direct immunofluoresence
antibody mediated tissue disease, good for establishing diagnosis
Manufactured second antibody with fluorescein marker is designed to bind to the primary disease causing antibody
* so if +ve result then disease present
Cannot put sample in formalin containing medium for transport (will cause binding to the site to be lost)
* Needs to be transported fresh and the lab processed quickly